Citations (18)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Feng Gao, Ming Li, Wenbin Liu & Wei Li. (2020) Inhibition of EGFR Signaling and Activation of Mitochondrial Apoptosis Contribute to Tanshinone IIA-Mediated Tumor Suppression in Non-Small Cell Lung Cancer Cells. OncoTargets and Therapy 13, pages 2757-2769.
Read now
Read now
Articles from other publishers (17)
Krista M. Dalton, Kateryna Krytska, Timothy L. Lochmann, Renata Sano, Colleen Casey, Alessia D'Aulerio, Qasim A. Khan, Giovanna Stein Crowther, Colin Coon, Jinyang Cai, Sheeba Jacob, Richard Kurupi, Bin Hu, Mikhail Dozmorov, Patricia Greninger, Andrew J. Souers, Cyril H. Benes, Yael P. Mossé & Anthony C. Faber. (2021)
Venetoclax-based Rational Combinations are Effective in Models of
MYCN
-amplified Neuroblastoma
. Molecular Cancer Therapeutics 20:8, pages 1400-1411.
Crossref
Crossref
Xinyou Yu, Feng Gao, Wei Li, Li Zhou, Wenbin Liu & Ming Li. (2020) Formononetin inhibits tumor growth by suppression of EGFR-Akt-Mcl-1 axis in non-small cell lung cancer. Journal of Experimental & Clinical Cancer Research 39:1.
Crossref
Crossref
Shota Yamamura, Nanami Goda, Hiroki Akizawa, Nanami Kohri, Ahmed Z. Balboula, Ken Kobayashi, Hanako Bai, Masashi Takahashi & Manabu Kawahara. (2020) Yes-associated protein 1 translocation through actin cytoskeleton organization in trophectoderm cells. Developmental Biology 468:1-2, pages 14-25.
Crossref
Crossref
Yuan-Chin Lee, Liang-Jun Wang, Chia-Hui Huang, Jing-Ting Chiou, Yi-Jun Shi & Long-Sen Chang. (2020) Inhibition of EGFR pathway promotes the cytotoxicity of ABT-263 in human leukemia K562 cells by blocking MCL1 upregulation. Biochemical Pharmacology 178, pages 114047.
Crossref
Crossref
Sarah Kehr, Tinka Haydn, Annika Bierbrauer, Barnabas Irmer, Meike Vogler & Simone Fulda. (2020) Targeting BCL-2 proteins in pediatric cancer: Dual inhibition of BCL-XL and MCL-1 leads to rapid induction of intrinsic apoptosis. Cancer Letters 482, pages 19-32.
Crossref
Crossref
Annika Bierbrauer, Maureen Jacob, Meike Vogler & Simone Fulda. (2020) A direct comparison of selective BH3-mimetics reveals BCL-XL, BCL-2 and MCL-1 as promising therapeutic targets in neuroblastoma. British Journal of Cancer 122:10, pages 1544-1551.
Crossref
Crossref
Feng Gao, Xinfang Yu, Ming Li, Li Zhou, Wenbin Liu, Wei Li & Haidan Liu. (2020) Deguelin suppresses non-small cell lung cancer by inhibiting EGFR signaling and promoting GSK3β/FBW7-mediated Mcl-1 destabilization. Cell Death & Disease 11:2.
Crossref
Crossref
Tao Shen, Xianshuo Cheng, Cuifeng Xia, Qiang Li, Yi Gao, Dingguo Pan, Xuan Zhang, Ce Zhang & Yunfeng Li. (2019) Erlotinib inhibits colon cancer metastasis through inactivation of TrkB‐dependent ERK signaling pathway. Journal of Cellular Biochemistry 120:7, pages 11248-11255.
Crossref
Crossref
Shawn J. Rice, Xin Liu, Hong-Gang Wang & Chandra P. Belani. (2019) EGFR mutations and AKT phosphorylation are markers for sensitivity to combined MCL-1 and BCL-2/xL inhibition in non-small cell lung cancer. PLOS ONE 14:5, pages e0217657.
Crossref
Crossref
Stefan E. G. Burdach, Mike-Andrew Westhoff, Maximilian Felix Steinhauser & Klaus-Michael Debatin. (2018) Precision medicine in pediatric oncology. Molecular and Cellular Pediatrics 5:1.
Crossref
Crossref
Olaia Aurtenetxe, Laura Zaldumbide, Asier Erramuzpe, Ricardo López, José I. López, Jesús M. Cortés, Rafael Pulido & Caroline E. Nunes-Xavier. (2018) DUSP5 expression associates with poor prognosis in human neuroblastoma. Experimental and Molecular Pathology 105:3, pages 272-278.
Crossref
Crossref
Jason E. Conage‐Pough & Lawrence H. Boise. (2018) Phosphorylation alters Bim‐mediated Mcl‐1 stabilization and priming. The FEBS Journal 285:14, pages 2626-2640.
Crossref
Crossref
Mumtahena Rahman, Shelley M. MacNeil, David F. Jenkins, Gajendra Shrestha, Sydney R. Wyatt, Jasmine A. McQuerry, Stephen R. Piccolo, Laura M. Heiser, Joe W. Gray, W. Evan Johnson & Andrea H. Bild. (2017) Activity of distinct growth factor receptor network components in breast tumors uncovers two biologically relevant subtypes. Genome Medicine 9:1.
Crossref
Crossref
Rachel Tanos, Dipan Karmali, Srilatha Nalluri & Kelly C. Goldsmith. (2016) Select Bcl-2 antagonism restores chemotherapy sensitivity in high-risk neuroblastoma. BMC Cancer 16:1.
Crossref
Crossref
André B.P. van Kuilenburg & Rutger Meinsma. (2016) The pivotal role of uridine-cytidine kinases in pyrimidine metabolism and activation of cytotoxic nucleoside analogues in neuroblastoma. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 1862:9, pages 1504-1512.
Crossref
Crossref
Donna Collins-McMillen, Jung Heon Kim, Maciej T. Nogalski, Emily V. Stevenson, Gary C. Chan, Joshua R. Caskey, Stephen J. Cieply & Andrew D. Yurochko. (2016) Human Cytomegalovirus Promotes Survival of Infected Monocytes via a Distinct Temporal Regulation of Cellular Bcl-2 Family Proteins. Journal of Virology 90:5, pages 2356-2371.
Crossref
Crossref
Jungoh Ham, Carlotta Costa, Renata Sano, Timothy L. Lochmann, Erin M. Sennott, Neha U. Patel, Anahita Dastur, Maria Gomez-Caraballo, Kateryna Krytska, Aaron N. Hata, Konstantinos V. Floros, Mark T. Hughes, Charles T. Jakubik, Daniel A.R. Heisey, Justin T. Ferrell, Molly L. Bristol, Ryan J. March, Craig Yates, Mark A. Hicks, Wataru Nakajima, Madhu Gowda, Brad E. Windle, Mikhail G. Dozmorov, Mathew J. Garnett, Ultan McDermott, Hisashi Harada, Shirley M. Taylor, Iain M. Morgan, Cyril H. Benes, Jeffrey A. Engelman, Yael P. Mossé & Anthony C. Faber. (2016) Exploitation of the Apoptosis-Primed State of MYCN-Amplified Neuroblastoma to Develop a Potent and Specific Targeted Therapy Combination. Cancer Cell 29:2, pages 159-172.
Crossref
Crossref